Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Elsa Mendoza has been living with the disease for years. Here's more on her battle and what it means to have Multiple ...

Fernando Mendoza prominently mentioned his mother in his Heisman Trophy acceptance speech. Here's what you should know about ...

By analysing MRI scans and a simple blood test from hundreds of patients, researchers identified patterns that reveal how ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Proving her illness created an illusion of wellness for columnist Ahna Crum, but a relapse after nine years showed her she ...

The FDA has rejected Sanofi's application seeking approval of tolebrutinib to treat certain forms of MS in its present form.

Lipoic acid offers no improvements in walking speed or other outcomes in patients with progressive multiple sclerosis ...

New Swedish research finds that people with highest microplastics and PFAS levels face double the risk of multiple sclerosis ...